NEWS ALERT! Biovac partners with global biopharmaceutical company, EuBiologics co.,Ltd for the technology transfer of a Meningococcal Meningitis vaccine for Africa. 💉 Biovac, today signed a memorandum of understanding (MOU) with global South Korean-based manufacturer EuBiologics, for the technology transfer of a Meningococcal Meningitis pentavalent conjugate vaccine. 💉 This collaboration is a significant development for Biovac, as it would allow for the local production and distribution of a life-saving vaccine for use across Africa. 💉 This Meningococcal vaccine candidate which is currently under clinical development and is planned to be locally manufactured in Africa for Africa is a particularly important vaccine as it protects against the relevant circulating serotypes for our continent. In addition, the vaccine will be a fully liquid vaccine which allows for ease of use. Morena Makhoana Yeong Ok Baik #VaccineManufacturing #TechnologyTransfer #Collaboration #EuBiologics #ProudlyBiovac Read more here: https://lnkd.in/eHcqmgQZ
Biovac
Pharmaceutical Manufacturing
Cape Town, Western Cape 64,007 followers
Science of Protecting Life
About us
Biovac was founded in 2003 to revive and restore South Africa’s vaccine manufacturing capabilities. We are an African based manufacturer contributing towards filling the gap that exists in the lack of African vaccine manufacturing capability. We recognise that we’ll only achieve this if we match scientific innovation through local biotechnology skills with the most advanced manufacturing technology and global partnerships. We work closely with local academic institutions, global pharmaceutical companies, the public sector as well as private sector. Some of our achievements are described below: We manufacture highly advanced vaccines on behalf of leading international biopharmaceutical companies. Biovac is licensed to manufacture a fully liquid hexavalent vaccine from Sanofi that targets and protects against six childhood diseases. In 2021, we envisage to start the manufacture of a multivalent pneumococcal conjugate vaccine from Pfizer. We supply over 15-million doses of vaccines a year in South Africa and neighbouring countries under strict cold chain conditions. We have built inhouse product development capability and technologies and have successfully out-licensed one of our technologies to international manufacturers. We are working to establish new safeguards against pathogens like group B streptococcus bacteria, a rising cause of sepsis and meningitis in newborns. To do this vital work, we rely on sophisticated technology and, above all, the skills and dedication of more than 350 highly trained team members. Along with our partners, we’ve invested over R800 million in infrastructure and skills development at our manufacturing facilities in Cape Town. These investments are resulting in estimated benefits of more than R500-million a year to the national economy.
- Website
-
http://www.biovac.co.za/
External link for Biovac
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Cape Town, Western Cape
- Type
- Partnership
- Founded
- 2003
- Specialties
- Sterile vaccine manufacturing, Quality Control Testing, Viewing, Labeling & Packaging , Public Sector Collaboration, and Cold Chain Distribution
Locations
-
Primary
Get directions
15 Alexandra Road
Pinelands
Cape Town, Western Cape, ZA
-
Get directions
1 Raapenberg Road Golf Park Mowbray
Cape Town, Western Cape, ZA
Employees at Biovac
Updates
-
Impact beyond borders. #ProudlyBiovac #TeamBiovac #ItJustGetsBetterAtBiovac
-
📣 Biovac Is a Top Employer! We’ve been recognized as a Top Employer by the Top Employers Institute! This achievement highlights our commitment to creating an incredible workplace where growth, culture & innovation thrive. We’re proud to be part of a company that puts people first, and this award is a testament to the amazing team we’ve built at Biovac. Thank you to everyone who makes Biovac such a special place to work! #TopEmployer #ProudlyBiovac #TeamBiovac
-
-
2025 is the Year of Healthy Habits! 😃 We asked our amazing team: What do you do to stay healthy every day? 💪From morning workouts to healthy snacks and mental wellness practices, we’ve gathered some awesome tips from our team to keep you feeling your best this year. Pick up a few ideas to add to your own routine! Let’s make 2025 our healthiest year yet! #ProudlyBiovac #ItJustGetsBetterAtBiovac #HealthyStaff
-
-
📣 Biovac Is a Top Employer! We’ve been recognized as a Top Employer by the Top Employers Institute! This achievement highlights our commitment to creating an incredible workplace where growth, culture & innovation thrive. We’re proud to be part of a company that puts people first, and this award is a testament to the amazing team we’ve built at Biovac. Thank you to everyone who makes Biovac such a special place to work! #TopEmployer #ProudlyBiovac #TeamBiovac
-
-
"Om Swastiastu from beautiful Bali! 🌴 #teamBiovac is thrilled to be at the IFC - International Finance Corporation Global Private Health Conference, where we're joining other global leaders to discuss advancing health systems strengthening in emerging markets. Our CEO, Dr Morena Makhoana & our Strategic Programme Supports Lead, Nicolaas Erasmus have been diving deep into how the private sector can drive sustainable health industries. From tech-enabled innovations to powerful public-private partnerships, the focus is on building integrated health systems that can meet the growing health challenges of low- and middle-income countries. On day 1 of the conference, Morena had the privilege of joining as a panellist for Breakout Session A: Local vs. Global: Key Considerations for Decision-Making in Pharma and Biotech. He tackled the big questions pharma and biotech companies face when choosing their path, with real-world case studies & insights, it made for an informative session! We’re excited to be part of these important conversations and to collaborate on shaping a healthier world! #IFC2025 #ProudlyBiovac #ProudlyBiotech #TeamBiovac
-
-
Welcome to Motherhood. 🤩 ❤️ You're about to embark on one of life's most precious journeys. Don't forget that vaccines play an important part in pregnancy. 🙌 Why not talk to your healthcare provider about the vaccines that are right for you and your baby during this period? #PregnancyAwarenessWeek 🤰
-
-
🌍 Guess who's in Cairo! #teamBiovac's CFO, Craig Mitchell, is at the Vaccine & Health Products Manufacturing Forum! Representing the manufacturer's perspective, Craig is sharing valuable insights alongside leaders from Africa CDC, Gavi, the Vaccine Alliance , European Investment Bank (EIB), and more. With the conference theme, "Together, we’re paving the way for a self-reliant health ecosystem in Africa," the forum is focused on boosting local vaccine production and shaping a future where Africa leads in health innovation. 🙌 “Instruments such as GAVI's AVMA are instrumental in advancing the African vaccine manufacturing agenda, however, there are still significant financing gaps faced by African manufacturers to unlock this financing. Innovative financing mechanisms, such as HDx, a new financing instrument from EIB with the support of the EC and Gates Foundation are helping to fill this gap." – Craig Mitchell, CFO #VaccineManufacturing #ProudlyBiovac #AfricaCDC #Gavi #EIB #HDx #EuropeanCommission #GatesFoundation #AVMA2025
-
-
What a fruitful visit from CEPI (Coalition for Epidemic Preparedness Innovations)) and the International Pandemic Preparedness Secretariat teams! We showcased Biovac and provided a behind-the-scenes look at the innovation that drives our work. #TeamBiovac is proud to play a key role in outbreak and pandemic preparedness, and drive the agenda of sustaining African manufacturing capability particularly in end to end vaccine manufacturing capability to support global vaccine access. We are more committed than ever to advancing vaccine innovation and contributing to the future of global health. #ProudlyBiovac #ProudlyBiotech #ItOnlyGetsBetterAtBiovac #PandemicPreparedness #CEPI #IPPS"
-